NCT04792684Recruiting
Collection of Samples USOPTIVAL Study
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance ("USOPTIVAL")
Source: ClinicalTrials.gov · Last updated 10 Nov 2025
Brief summary (registry, in English)
A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1300 (estimated)
- First submitted
- 8 Mar 2021
- Start date
- 30 Dec 2020
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Universal Diagnostics
- Diseases
- Colorectal cancer
- NCT number
- NCT04792684
What you commit to
- Study type: Observational
- Planned participants: 1300
- From 30 Dec 2020 to the primary completion date, 30 Dec 2025
- 16 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects having undergone previous partial surgical removal of one or more portions of their colon due to a reason other than colorectal cancer.
- The patient has a known or documented previous or current medical history of infectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV, etc.), including patients that have been treated, are currently being treated, or have not been treated for that conditions.
Other illness
- Subject has a current diagnosis of cancer.
- Arms A \& B:
- Subject has a personal history of aerodigestive or digestive tract cancers.
- A significant disease which, in the Investigator's opinion, would exclude the subject from the study.
- Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent.
Age
- Has a known diagnosis or personal history of any of the following high-risk indications for colorectal cancer:
- Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease.
- Familial adenomatous polyposis ("FAP", including attenuated FAP).
- Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "Lynch Syndrome").
- Serrated polyposis syndrome
- 2 first-degree relatives (e.g., parents, siblings, and offspring) who have been diagnosed with colon cancer.
- One first-degree relative with CRC diagnosed before the age of 60.
Other
- Arm A Only:
- 1\. Subject with curative biopsy during colonoscopy.
- Arm B Only:
- Subjects with positive FIT Test results in the 6 months preceding enrollment.
- Legal incapacity or limited mental capacity.
- The patient is known to be pregnant when recruited or during her participation in the study.
Who the study is looking for
- Arm A:
- Must be 45-84 years of age.
- Must have a suspected advanced adenoma or be newly diagnosed with CRC, still not resected, and scheduled for surgery.
- Able to comprehend, sign, and date the written informed consent document.
- Arm B:
- Must be 45-84 years of age.
- Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.
- Able to comprehend, sign, and date the written informed consent document.
Age in the registry: 45 years to 84 years · Sex: All · Accepts healthy volunteers
Sites (16)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Completed |
| Precision Recearch Institute Coordinator of this site? Confirm its status | Chula Vista | United States | Completed |
| Center for Gastrointestinal Disorders Coordinator of this site? Confirm its status | Hollywood | United States | Completed |
| Vilo Research Group Coordinator of this site? Confirm its status | Houston | United States | Completed |
| Lakeland Regional Cancer Center Coordinator of this site? Confirm its status | Lakeland | United States | Recruiting |
| Ochsner Clinic Coordinator of this site? Confirm its status | New Orleans | United States | Completed |
| Mid Hudson Medical Research Coordinator of this site? Confirm its status | New Windsor | United States | Recruiting |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
| Fox Chase Cancer Center Coordinator of this site? Confirm its status | Philadelphia | United States | Completed |
| Gastroenterology Consultants of SW Virginia Coordinator of this site? Confirm its status | Raonoke | United States | Completed |
| Precision Research Institute Coordinator of this site? Confirm its status | San Diego | United States | Completed |
| Medical Associates Research Group Coordinator of this site? Confirm its status | San Diego | United States | Completed |
| Springfield Clinic Coordinator of this site? Confirm its status | Springfield | United States | Recruiting |
| Clinical Trials Network Coordinator of this site? Confirm its status | Union City | United States | Completed |
| Frontier Clinical Research Coordinator of this site? Confirm its status | Uniontown | United States | Completed |
| Clinical Research of California Coordinator of this site? Confirm its status | Walnut Creek | United States | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.